Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.49
-0.15 (-2.66%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Lifecore Biomedical Revenue
Lifecore Biomedical had revenue of $23.19M in the quarter ending March 31, 2026, a decrease of -34.02%. This brings the company's revenue in the last twelve months to $126.49M, down -2.93% year-over-year. In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth.
Revenue (ttm)
$126.49M
Revenue Growth
-2.93%
P/S Ratio
1.59
Revenue / Employee
$338,913
Employees
382
Market Cap
205.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 25, 2025 | 128.87M | 606.00K | 0.47% |
| May 26, 2024 | 128.26M | 24.99M | 24.20% |
| May 28, 2023 | 103.27M | -8.00M | -7.19% |
| May 29, 2022 | 111.27M | 10.40M | 10.31% |
| May 30, 2021 | 100.87M | -59.19M | -36.98% |
| May 31, 2020 | 160.07M | -397.49M | -71.29% |
| May 26, 2019 | 557.56M | 33.33M | 6.36% |
| May 27, 2018 | 524.23M | 54.45M | 11.59% |
| May 28, 2017 | 469.78M | -7.14M | -1.50% |
| May 29, 2016 | 476.92M | -62.34M | -11.56% |
| May 31, 2015 | 539.26M | 62.44M | 13.10% |
| May 25, 2014 | 476.81M | 35.11M | 7.95% |
| May 26, 2013 | 441.71M | 124.16M | 39.10% |
| May 27, 2012 | 317.55M | 40.82M | 14.75% |
| May 29, 2011 | 276.73M | 44.64M | 19.23% |
| May 30, 2010 | 232.09M | 3.54M | 1.55% |
| May 31, 2009 | 228.55M | -2.64M | -1.14% |
| May 25, 2008 | 231.19M | 25.76M | 12.54% |
| May 27, 2007 | 205.43M | -23.70M | -10.34% |
| May 28, 2006 | 229.13M | 24.41M | 11.92% |
| May 29, 2005 | 204.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 514.70M |
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 232.40M |
| Canopy Growth | 203.04M |
| Organigram Global | 196.43M |
| Anika Therapeutics | 116.26M |
| Assertio Holdings | 102.16M |
| SIGA Technologies | 93.78M |
LFCR News
- 18 hours ago - Lifecore signs agreement with global pharmaceutical company - TheFly
- 19 hours ago - Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company - GlobeNewsWire
- 11 days ago - Lifecore Biomedical Transcript: AGM 2026 - Transcripts
- 13 days ago - Lifecore signs manufacturing pact with ophthalmic disease management provider - TheFly
- 13 days ago - Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer - GlobeNewsWire
- 25 days ago - Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference - GlobeNewsWire
- 4 weeks ago - Lifecore Biomedical to Participate at CDMO Live Europe - GlobeNewsWire
- 5 weeks ago - Lifecore reports Q1 EPS (43c), consensus (29c) - TheFly